Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells

References

• RossouwJEAndersonGLPrenticeRLWriting Group for the Women’s Health Initiative InvestigatorsRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trialJAMA2002288332133312117397
   PubMed Web of Science ®Google Scholar
• ChlebowskiRTHendrixSLLangerRDWHI InvestigatorsInfluence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative Randomized trialJAMA2003289243243325312824205
   PubMed Web of Science ®Google Scholar
• RossRKPaganini-HillAWanPCPikeMCEffect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestinJ Natl Cancer Inst200092432833210675382
   PubMed Web of Science ®Google Scholar
• BeralVMillion Women Study CollaboratorsBreast cancer and hormone-replacement therapy in the Million Women studyLancet2003362938241942712927427
   PubMed Web of Science ®Google Scholar
• HolmbergLIversenO-EERudenstamCMIncreased risk of recurrence after hormone replacement therapy in breast cancer survivorsJ Natl Cancer Inst2008100747548218364505
   PubMedGoogle Scholar
• LiangYBenakanakereIBesch-WillifordCHyderRSEllersieckMRHyderSMSynthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude miceMenopause20101751040104720461021
   PubMed Web of Science ®Google Scholar
• GoyetteSLiangYMafuvadzeBCookMMunirMHyderSNatural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitroBreast Cancer Targets Ther20179347357
   Web of Science ®Google Scholar
• ChenKHuangY-HHChenJ-LLUnderstanding and targeting cancer stem cells: therapeutic implications and challengesActa Pharmacol Sin201334673274023685952
   PubMed Web of Science ®Google Scholar
• ChafferCLWeinbergRAA perspective on cancer cell metastasisScience201133160241559156421436443
   PubMed Web of Science ®Google Scholar
• GinestierCHurMHCharafe-JauffretEALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeCell Stem Cell20071555556718371393
   PubMed Web of Science ®Google Scholar
• IstvanESDeisenhoferJStructural mechanism for statin inhibition of HMG-CoA reductaseScience200129255191160116411349148
   PubMed Web of Science ®Google Scholar
• McTaggartSJIsoprenylated proteinsCell Mol Life Sci200663325526716378247
   PubMed Web of Science ®Google Scholar
• ThomaRSchulz-GaschTD’ArcyBInsight into steroid scaffold formation from the structure of human oxidosqualene cyclaseNature2004432701311812215525992
   PubMed Web of Science ®Google Scholar
• MafuvadzeBLiangYHyderSMCholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptorOncol Rep20143241727173325051231
   PubMed Web of Science ®Google Scholar
• LiangYMafuvadzeBAebiJDHyderSMCholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cellsOnco Targets Ther201693223323227313468
   PubMed Web of Science ®Google Scholar
• LiangYBesch-WillifordCAebiJDCholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071Breast Cancer Res Treat20141461516224878988
   PubMed Web of Science ®Google Scholar
• JacobsenBMHorwitzKBProgesterone receptors, their isoforms and progesterone regulated transcriptionMol Cell Endocrinol20123571–2182921952082
   PubMed Web of Science ®Google Scholar
• HoellerDDikicITargeting the ubiquitin system in cancer therapyNature2009458723743844419325623
   PubMed Web of Science ®Google Scholar
• D’AbreoNHindenburgAASex hormone receptors in breast cancerVitam Horm2013939913323810004
   PubMed Web of Science ®Google Scholar
• FisherBRedmondCFisherERCaplanRRelative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06J Clin Oncol198867107610872856862
   PubMed Web of Science ®Google Scholar
• LiangYBesch-WillifordCBrekkenRAHyderSMProgestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeuticsCancer Res200767209929993617942925
   PubMed Web of Science ®Google Scholar
• BenakanakereIBesch-WillifordCSchnellJNatural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley ratsClin Cancer Res200612134062407116818706
   PubMed Web of Science ®Google Scholar
• PontaHShermanLHerrlichPACD44: from adhesion molecules to signalling regulatorsNat Rev Mol Cell Biol200341334512511867
   PubMed Web of Science ®Google Scholar
• ZöllerMCD44: can a cancer-initiating cell profit from an abundantly expressed molecule?Nat Rev Cancer201111425426721390059
   PubMed Web of Science ®Google Scholar
• BourguignonLYWongGEarleCChenLHyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinomaJ Biol Chem201228739328003282422847005
   PubMed Web of Science ®Google Scholar
• GorinAGabitovaLAstsaturovIRegulation of cholesterol biosynthesis and cancer signalingCurr Opin Pharmacol201212671071622824431
   PubMed Web of Science ®Google Scholar
• MaioneFOliaro-BossoSMedaCThe cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis disseminationSci Rep20155905425761781
   PubMed Web of Science ®Google Scholar
• HyderSMChiappettaCStancelGMPharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cellsInt J Cancer200192446947311304678
   PubMed Web of Science ®Google Scholar
• FaivreEJLangeCAProgesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cellsMol Cell Biol200727246648017074804
   PubMed Web of Science ®Google Scholar
• BriskenCHeinemanAChavarriaTEssential function of Wnt-4 in mammary gland development downstream of progesterone signalingGenes Dev200014665065410733525
   PubMed Web of Science ®Google Scholar
• JangGBKimJYChoSDBlockade of Wnt/beta-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotypeSci Rep201551246526202299
   PubMed Web of Science ®Google Scholar
• Mejia-PousCDamiolaFGandrillonOCholesterol synthesis-related enzyme oxidosqualene cyclase is required to maintain self-renewal in primary erythroid progenitorsCell Prolif201144544145221951287
   PubMed Web of Science ®Google Scholar
• VidalSJRodriguez-BravoVGalskyMCordon-CardoCDomingo-DomenechJTargeting cancer stem cells to suppress acquired chemotherapy resistanceOncogene201433364451446324096485
   PubMed Web of Science ®Google Scholar